Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
about
Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity
description
im November 2018 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 December 2018
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в листопаді 2018
@uk
name
Use of human induced pluripote ...... to assess drug cardiotoxicity
@en
Use of human induced pluripote ...... to assess drug cardiotoxicity
@nl
type
label
Use of human induced pluripote ...... to assess drug cardiotoxicity
@en
Use of human induced pluripote ...... to assess drug cardiotoxicity
@nl
prefLabel
Use of human induced pluripote ...... to assess drug cardiotoxicity
@en
Use of human induced pluripote ...... to assess drug cardiotoxicity
@nl
P2093
P50
P1433
P1476
Use of human induced pluripote ...... to assess drug cardiotoxicity
@en
P2093
Joseph C Wu
Mark Mercola
Paul W Burridge
Tomoya Kitani
P304
P356
10.1038/S41596-018-0076-8
P407
P577
2018-12-01T00:00:00Z